142 related articles for article (PubMed ID: 2871950)
1. Growth hormone response to low dose intravenous injections of growth hormone releasing factor in obese and normal weight women.
Kopelman PG; Noonan K
Clin Endocrinol (Oxf); 1986 Feb; 24(2):157-64. PubMed ID: 2871950
[TBL] [Abstract][Full Text] [Related]
2. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
Kopelman PG; Noonan K; Goulton R; Forrest AJ
Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
[TBL] [Abstract][Full Text] [Related]
3. Growth induced by pulsatile infusion of an amidated fragment of human growth hormone releasing factor in normal and GHRF-deficient rats.
Clark RG; Robinson IC
Nature; 1985 Mar 21-27; 314(6008):281-3. PubMed ID: 2858818
[TBL] [Abstract][Full Text] [Related]
4. Does growth hormone releasing factor desensitize the somatotroph? Interpretation of responses of growth hormone during and after 10-hour infusion of GRF 1-29 amide in man.
Davis JR; Sheppard MC; Shakespear RA; Lynch SS; Clayton RN
Clin Endocrinol (Oxf); 1986 Feb; 24(2):135-40. PubMed ID: 2871948
[TBL] [Abstract][Full Text] [Related]
5. Low-dose growth hormone-releasing hormone tests: a dose-response study.
Spoudeas HA; Winrow AP; Hindmarsh PC; Brook CG
Eur J Endocrinol; 1994 Sep; 131(3):238-45. PubMed ID: 7921207
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
Massoud AF; Hindmarsh PC; Brook CG
Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
[TBL] [Abstract][Full Text] [Related]
7. Synergism and diurnal variations of human growth hormone-releasing factor (1-29)NH2 and thyrotropin-releasing factor on growth hormone release in dairy calves.
Lapierre H; Petitclerc D; Pelletier G; Dubreuil P; Morisset J; Gaudreau P; Couture Y; Brazeau P
Domest Anim Endocrinol; 1987 Oct; 4(4):207-14. PubMed ID: 2907311
[TBL] [Abstract][Full Text] [Related]
8. Dose response of two synthetic human growth hormone-releasing factors on growth hormone release in heifers and pigs.
Peticlerc D; Pelletier G; Lapierre H; Gaudreau P; Couture Y; Dubreuil P; Morisset J; Brazeau P
J Anim Sci; 1987 Oct; 65(4):996-1005. PubMed ID: 2889716
[TBL] [Abstract][Full Text] [Related]
9. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats.
Clark RG; Robinson IC
J Endocrinol; 1985 Sep; 106(3):281-9. PubMed ID: 2864380
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(1-29)-NH2, on growth hormone secretion in normal men: dose-response relationships.
Vance ML; Evans WS; Kaiser DL; Burke RL; Rivier J; Vale W; Thorner MO
Clin Pharmacol Ther; 1986 Dec; 40(6):627-33. PubMed ID: 3096623
[TBL] [Abstract][Full Text] [Related]
12. Periodic interactions of GH-releasing factor and somatostatin can augment GH release in vitro.
Weiss J; Cronin MJ; Thorner MO
Am J Physiol; 1987 Nov; 253(5 Pt 1):E508-14. PubMed ID: 2891301
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary restriction and repeated growth hormone-releasing factor injections on growth hormone response to growth hormone-releasing factor in obese subjects.
Csizmadi I; Brazeau P; Serri O
Metabolism; 1989 Oct; 38(10):1016-21. PubMed ID: 2507875
[TBL] [Abstract][Full Text] [Related]
14. The response of obese subjects to continuous infusion of human pancreatic growth hormone-releasing factor 1-44.
Davies RR; Turner SJ; Cook D; Alberti KG; Johnston DG
Clin Endocrinol (Oxf); 1985 Nov; 23(5):521-5. PubMed ID: 3936648
[TBL] [Abstract][Full Text] [Related]
15. The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.
Giustina A; Bossoni S; Bodini C; Doga M; Girelli A; Buffoli MG; Schettino M; Wehrenberg WB
Metabolism; 1991 May; 40(5):519-23. PubMed ID: 2023538
[TBL] [Abstract][Full Text] [Related]
16. The inter- and intra-subject variabilities of plasma GH response to human growth hormone-releasing hormone (1-44) NH2 in men.
Hotta M; Shibasaki T; Masuda A; Imaki T; Wakabayashi I; Demura H; Ling N; Shizume K
Endocrinol Jpn; 1985 Oct; 32(5):673-80. PubMed ID: 3937723
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
Chihara K; Kashio Y; Abe H; Minamitani N; Kaji H; Kita T; Fujita T
J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
Hartman ML; Farello G; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
[TBL] [Abstract][Full Text] [Related]
19. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
[TBL] [Abstract][Full Text] [Related]
20. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
